Contributing Editors
-
US Pharma Reshoring: The Full Policy Timeline
9/17/2026
As policy shifts and manufacturing investments reshape pharma supply chains, capacity constraints and global dependencies persist. Explore the implications for long-term resilience.
-
The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
9/17/2026
The wrong regulatory filing sequence can close faster pathways, delay importation, and consume shelf life. Here’s how regulatory strategy can reshape clinical supply.
-
What FDA Inspectors Want From Your OOS File
9/16/2026
Read enough FDA warning letters and a pattern emerges: Investigators rarely cite a retest that was performed badly. They cite a retest that nobody justified in writing. Let's take a closer look.
-
You Can't CAPA What You Can't Classify
9/16/2026
An LLM or agentic error can occur with no component broken in any way the QMS recognizes. Classifying it takes two fields: the error type and the error origination point.
-
AI Fills The Decision-Making Gaps In Process Analytical Technology
9/16/2026
When combined, artificial intelligence and PAT help move beyond reactive quality testing to proactive and anticipatory process management.
-
Why Supplier Diversification Doesn't Ensure Supply Safety
9/15/2026
Recent events show supplier count to be an incomplete measure of resilience. The more useful question is whether separate supply arrangements remain independent when a critical material, capability, or route fails.
-
Oral Combination Therapies: Navigating Development Complexities
9/10/2026
We discuss how delivery strategy influences development decisions, learnings from advancing IHL-42X, and Latham's perspective on the future of patient-centric drug delivery.
-
Building Trust In AI For Computerized System Validation
9/4/2026
Using AI for CSV might feel like the students are grading their own papers. One consultant explains why it's not the same, namely, there are no subjective judgment calls.
-
When To Trust And When To Verify AI-Enabled Validation Systems
9/3/2026
Computer software assurance, coupled with AI, can help validation teams reduce redundant work and spend more time on patient-centric issues.
-
CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture
9/2/2026
Discover strategies for risk-based governance, AI-enabled quality management, stronger collaboration, and fostering a culture that supports long-term operational excellence.